Form C - Offering Statement:
SEC Accession No. 0001729427-18-000001
Filing Date
2018-03-13
Accepted
2018-03-13 15:11:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 5241
2 CNS PHARMACEUTICALS FORM C cnspharmaceuticalsformc.pdf EX-99 14172861
  Complete submission text file 0001729427-18-000001.txt   19516038
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-24084 | Film No.: 18686243